Ticagrelor China Pharmacokinetic/Pharmacodynamic Study

Clinical trial NCT02064985 · COMPLETED

Trial details

NCT number: NCT02064985
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Stable Coronary Heart Disease (CHD)

Start date: 2014-02-01
Primary completion: 2014-11-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.